WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'3401 Infant (under 12 months) mortality rate: 262
GDP / capita (US$): 7'2951 Child (under 5 years) mortality rate: 322

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 15'468  15'083  14'707  14'342  13'989  11'204  8'890  7'001 
Births 480  474  469  463  458  412  349  302 
Surviving infants 469  463  457  451  445  395  328  276 
Pop. less than 5 years 2'250  2'215  2'184  2'161  2'134  1'859  1'517  1'262 
Pop. less than 15 years 6'254  6'151  6'050  5'955  5'856  4'937  4'034  3'177 
Female 15-49 years 3'875  3'760  3'647  3'534  3'428  2'621  1'952  1'545 

Number of reported case

(Click for retrospective incidence data for Guatemala)
Diphtheria
Japanese encephalitis
Measles 8'802  2'703 
Mumps 143 
Pertussis 34  273  146  130  1'513 
Polio* 287 
Rubella 276 
Rubella (CRS)
Tetanus (neonatal) 60 
Tetanus (total) 11  60  60 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guatemala)
Vaccine year result method % card seen                                                
BCG 2007  97  MCH   87  88  94  91  100  93  95  62  36 
DTP1 2007  96  MCH   87  97  99*  94  97  94  94 
DTP3 2007  84  MCH   87  85  96  88  94  92  95  66  43 
HepB_BD          32  35  31  15 
HepB3          85  96  88  94  92 
Hib3          85  96  88  94  92 
JapEnc         
MCV          85  93  89  93  92  86  68  23 
MCV2          59 
PCV1          73 
PCV3         
Pol3 2007  85  MCH   87  84  94  88  94  92  93  74  43 
Rota1          92  99*  81  30 
Rota_last          81  81  71  38 
Rubella1          85  93  89  93  92 
TT2plus 2001  49  MCH   69  99*  99*  22  27 
PAB         
VAD1          46  34  63  82  36  49 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guatemala)
BCG 88  94  91  99  93  95  62  36 
DTP1 97  96  94  96  94  94  86  68 
DTP3 85  96  88  94  92  81  66  43 
HepB3 85  96  88  94  92 
HepB_BD 32  35  31  15 
Hib3 85  96  85  94  92 
MCV 85  93  89  93  92  86  68  23 
MCV2
PAB 85  85  85  85  71  67  44 
PCV3
Pol3 84  94  88  94  92  80  74  43 
Rota_last 81  81  71  38 

Number of districts in the country 334  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 40
From 80 to 89% 20
From 50 to 79% 30
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepB birth; Yes and 3 doses for adults in risk groups
Influenza 6 months to 5 years; > 18 years; risk groups
MMR 12 months; Yes
MR > 14 years; Yes travelers and risk groups
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4 months; 1 year; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +4 weeks; +6 months; +1, +1 year; Yes or 1st contact; +4 weeks; +6 months; +10, +10 years (if not at risk)
VitaminA 6-59, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  No  Yes  No  No  No 
What years does the MYP cover? number   2012-2016    2011-2015       
Nº of districts with microplans that include activities to raise immunization coverage number 334    335  332  333  332 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No       

System performance

Total Nº districts in country number 334  334  335  332  333  332  332 
Nº districts with DTP3 coverage >=80% number 201  305  256  266  263  312  56 
% of districts with DTP3 coverage >=80% From 0 to 100% 60  91  76  80  79  94  17 
Nº districts with measles (MCV1) coverage >=95% number 111  130  71  179  162  231   
% of districts with MCV1 coverage >=95% From 0 to 100% 33  39  21  54  49  70   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  99   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.